HI
PBYI icon

HBK Investments’s Puma Biotechnology PBYI Stock Holding History

HBK Investments’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-29,161
Closed -$1.73M – 1303
2018
Q2 		$1.73M Sell
29,161
-43,842
-60% -$2.54M 0.01% 515
2018
Q1 		$4.97M Buy
73,003
+47,203
+183% +$3.53M 0.03% 274
2017
Q4 		$2.55M Sell
25,800
-29,258
-53% -$3.27M 0.02% 393
2017
Q3 		$6.59M Sell
55,058
-38,935
-41% -$3.62M 0.04% 218
2017
Q2 		$8.21M Sell
93,993
-62,604
-40% -$3.5M 0.05% 178
2017
Q1 		$5.83M Buy
156,597
+80,197
+105% +$2.93M 0.05% 201
2016
Q4 		$2.35M Buy
76,400
+58,260
+321% +$2.52M 0.02% 306
2016
Q3 		$1.22M Buy
+18,140
New +$917K 0.01% 472
2015
Q3 		– Sell
-26,079
Closed -$3.04M – 1099
2015
Q2 		$3.04M Buy
26,079
+22,548
+639% +$4.08M 0.03% 311
2015
Q1 		$834K Buy
+3,531
New +$755K 0.01% 608
2014
Q4 		– Sell
-4,900
Closed -$1.17M – 1086
2014
Q3 		$1.17M Buy
4,900
+760
+18% +$156K 0.02% 499
2014
Q2 		$273K Sell
4,140
-32,060
-89% -$2.28M 0.01% 813
2014
Q1 		$3.77M Buy
36,200
+27,700
+326% +$3.26M 0.07% 219
2013
Q4 		$880K Buy
+8,500
New +$499K 0.02% 499

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

HBK Investments's PBYI Position: Q3 2018 in Review

HBK Investments sold out of Puma Biotechnology (PBYI) in Q3 2018, closing a stake of 29,161 shares — an estimated $1.73M sold.

HBK Investments first reported a position in PBYI in Q4 2013 and held it in 14 quarters. The position peaked at $8.21M in Q2 2017. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2018.

  • HBK Investments reported no remaining Puma Biotechnology position as of Q3 2018 after selling out during the quarter.
  • HBK Investments sold 29,161 Puma Biotechnology shares in Q3 2018, an estimated $1.73M.
  • HBK Investments first reported a position in Puma Biotechnology in Q4 2013 and held it in 14 quarters.
  • HBK Investments's Puma Biotechnology position peaked at $8.21M in Q2 2017.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2018.

Based on HBK Investments's 13F filing for Q3 2018, filed 14 Nov 2018.